Evidence map›Paper›PMID 11829736›Full record

ArticleThe Biochemical journal2002

Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective.

Scott D Williams, Roberta A Gottlieb

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 126 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Mitochondrial HAnnual review of physiology · 2022
    Review
  7. iPLACells · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Scott D WilliamsDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, U.S.A.
Roberta A Gottlieb
Scripps Research Institute · US

Funding

Rescue and Role of Complex I in myocardial ischemic injuryR01HL060590 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI GOTTLIEB, ROBERTA A. · 1998 to 2011
$3.6M
SUPPLEMENT TO INVESTIGATIVE HEMATOLOGYT32DK007022 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI SOLOMON, DANIEL RENEE · 1986 to 2009
$2.3M
MITOCHONDRIAL ROLE IN CASPASE PROCESSING AND ACTIVATIONR01HL061518 · NHLBI · SCRIPPS RESEARCH INSTITUTE · PI GOTTLIEB, ROBERTA A. · 1999 to 2003
$1.1M
NHLBI NIH HHS HL 61518NHLBI NIH HHS R01 HL 60590NIDDK NIH HHS 5T32 DK 07022-21
6 · The paper itself

Abstract

Calcium-independent phospholipase A(2) (iPLA(2)) is the predominant phospholipase A(2) present in myocardium, and its pathophysiological role in acute myocardial infarction has been suggested by the rapid increase in membrane-associated iPLA(2) activity during myocardial ischaemia and reperfusion (I/R). We therefore examined iPLA(2) in mitochondrial fractions prepared from Langendorff-perfused adult rabbit hearts. Our studies indicate that iPLA(2)beta is present in rabbit heart mitochondrial inner membranes with no apparent translocation during ischaemia, I/R or preconditioning. Mitochondrion-associated iPLA(2) was catalytically competent and exhibited 2-, 3- and 2.5-fold increases in measured iPLA(2) activity following ischaemia, I/R and preconditioning, respectively, when compared with the activity of iPLA(2) measured in mitochondria from control hearts. Mitochondrial phospholipids are essential for maintaining the ordered structure and function of the organelle. I/R resulted in a rapid overall decrease in phosphatidylcholine and phosphatidylethanolamine glycerophospholipid species, as determined by electrospray ionization MS, that was partially alleviated by pretreatment of hearts with the iPLA(2)-specific inhibitor, bromoenol lactone (BEL). Pretreatment of I/R hearts with 10 microM BEL significantly reduced the infarct size almost to that of continuously perfused hearts and was cardioprotective only when administered prior to ischaemia. Cardioprotection by BEL was reversed by the simultaneous perfusion of 100 microM 5-hydroxydecanoate, implicating the mitochondrial K(ATP) channel in BEL-mediated protection from I/R. Preconditioning also significantly reduced the infarct size in response to I/R but protection was lost by concurrent perfusion of 10 microM arachidonic acid. Taken together, these data strongly implicate mitochondria-associated iPLA(2) in the signal transduction of myocardial I/R injury.

Indexed as

AnimalsArachidonic AcidCalciumCatalysisGlycerophospholipidsIon Channel GatingMitochondria, HeartMolecular WeightMyocardial InfarctionPhospholipases APhospholipases A2PhospholipidsPotassium ChannelsRabbitsReperfusion InjurySignal TransductionArachidonic AcidCalciumGlycerophospholipidsPhospholipases APhospholipases A2PhospholipidsPotassium Channels

Identifiers

PMID11829736
PMCPMC1222356
OpenAlexW2046292799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.